Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Anges MG Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

AnGes MG Q3 FY12/16 Report Update

Following the results announcement we have updated our report to reflect additional information obtained during our meeting w...

01 Nov 2016 Shared Research Inc. 45 $0.00

Thomson Reuters Stock Report - Anges MG Inc (4563-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

アンジェスMG 2016年12月期第3四半期決算レポート更新

2016年10月28日、決算発表後の取材を踏まえ、アンジェスMGの2016年12月期第3四半期決算レポートを更新した。 添付資料を参照。 詳しくは(http://www.sharedresearch.jp)。

28 Oct 2016 Shared Research Inc. 44 $0.00

AnGes MG Q3 FY12/16 Flash Update

Onoctober 24, 2016, AnGes MG announced Q3 FY12/16 results. Shared Research has updated its full report to reflect the news. P...

24 Oct 2016 Shared Research Inc. 3 $0.00

アンジェスMG 2016年12月期第3四半期決算発表

2016年10月24日、アンジェスMGが2016年12月期第3四半期決算を発表した。 添付資料を参照。 詳しくは(http://www.sharedresearch.jp)。

24 Oct 2016 Shared Research Inc. 3 $0.00

Wright Investors Service Comprehensive Report for Anges MG Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 Oct 2016 Wright Reports 65 $75.00

AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review

AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review Summary AnGes MG, Inc. (AnGes) is a biopharmaceutical co...

07 Oct 2016 GlobalData 72 $300.00

AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review

AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review Summary AnGes MG, Inc. (AnGes) is a biopharmaceutical co...

19 Sep 2016 GlobalData 72 $300.00

AnGes MG 1H FY12/16 Report Update

Following the results announcement we have updated our report to reflect additional information obtained during our meeting w...

30 Aug 2016 Shared Research Inc. 44 $0.00